YANG Tao, WANG Deli, LI Xiao, LIN Lifang, TIAN Li. Effect and mechanism of Xuanfu Daizhe Decoction on proliferation, migration and invasion activities of esophageal cancer cells[J]. Journal of Clinical Medicine in Practice, 2025, 29(2): 42-47. DOI: 10.7619/jcmp.20244890
Citation: YANG Tao, WANG Deli, LI Xiao, LIN Lifang, TIAN Li. Effect and mechanism of Xuanfu Daizhe Decoction on proliferation, migration and invasion activities of esophageal cancer cells[J]. Journal of Clinical Medicine in Practice, 2025, 29(2): 42-47. DOI: 10.7619/jcmp.20244890

Effect and mechanism of Xuanfu Daizhe Decoction on proliferation, migration and invasion activities of esophageal cancer cells

More Information
  • Received Date: October 16, 2024
  • Revised Date: December 23, 2024
  • Objective 

    To investigate the effect and mechanism of Xuanfu Daizhe Decoction on the proliferation, migration, and invasion activities of esophageal cancer cells.

    Methods 

    Human esophageal cancer cell line EC109 was treated with Xuanfu Daizhe Decoction at different concentrations, and the cells were divided into high-concentration group (200 μg/mL), medium-concentration group (100 μg/mL), low-concentration group (50 μg/mL), and blank group (0 μg/mL) based on the concentration. CCK-8 assay, wound healing assay, and Transwell invasion assay were used to detect the proliferation, migration, and invasion activities of the cells in each group, respectively. Western blot and cellular immunofluorescence staining were employed to detect the protein expression levels of glycolysis-related enzymes [hexokinase 2 (HK2), lactate dehydrogenase A (LDHA), and phosphofructokinase 1 (PFK1)] in the cells of each group, and real-time quantitative fluorescent polymerase chain reaction (qRT-PCR) was used to detect the relative expression levels of mRNA encoding these enzymes. A nude mouse tumor-bearing model was established and divided into control group and Xuanfu Daizhe Decoction-fed group (20 mg/kg) to observe the effect of Xuanfu Daizhe Decoction on the growth of esophageal cancer in vivo.

    Results 

    The results of CCK-8 assay, wound healing assay, and Transwell invasion assay showed that Xuanfu Daizhe Decoction could inhibit the proliferation, migration, and invasion activities of EC109 cells in a concentration-dependent manner. Western blot and cellular immunofluorescence analysis revealed that compared with the blank group, the protein expression levels of HK2, LDHA, and PFK1 in the low-concentration, medium-concentration, and high-concentration groups were decreased (P < 0.05). The qRT-PCR results showed that compared with the blank group, the relative expression levels of HK2 mRNA, LDHA mRNA, and PFK1 mRNA in the low-concentration, medium-concentration, and high-concentration groups were all reduced(P < 0.01 or P < 0.000 1). The tumor volume in the subcutaneous tissue on the back of nude mice in the Xuanfu Daizhe Decoction-fed group was smaller than that in the control group, and the protein expression level of LDHA in the tumor tissue of the Xuanfu Daizhe Decoction-fed group was lower than that in the control group, while the expression level of the pro-apoptotic protein Bax was higher than that in the control group (P < 0.05).

    Conclusion 

    Xuanfu Daizhe Decoction can inhibit the glycolysis process of esophageal cancer cells in a concentration-dependent manner, thereby inhibiting cell proliferation, migration, invasion, and tumor growth in vivo.

  • [1]
    BÖHME F, RACZ K, SEBESTA C J, et al. Das ösophaguskarzinom[J]. Wien Med Wochenschr, 2023, 173(9): 209-215.
    [2]
    ZHU H, MA X, YE T, et al. Esophageal cancer in China: Practice and research in the new era[J]. Int J Cancer, 2023, 152(9): 1741-1751. doi: 10.1002/ijc.34301
    [3]
    LUENGO A, GUI D Y, VANDER HEIDEN M G. Targeting metabolism for cancer therapy[J]. Cell Chem Biol, 2017, 24(9): 1161-1180. doi: 10.1016/j.chembiol.2017.08.028
    [4]
    BARBA I, CARRILLO-BOSCH L, SEOANE J. Targeting the Warburg effect in cancer: where do we stand[J]. Int J Mol Sci, 2024, 25(6): 3142. doi: 10.3390/ijms25063142
    [5]
    CHELAKKOT C, CHELAKKOT V S, SHIN Y, et al. Modulating glycolysis to improve cancer therapy[J]. Int J Mol Sci, 2023, 24(3): 2606. doi: 10.3390/ijms24032606
    [6]
    ZHENG S, LI H, LI Y, et al. The emerging role of glycolysis and immune evasion in gastric cancer[J]. Cancer Cell Int, 2023, 23(1): 317. doi: 10.1186/s12935-023-03169-1
    [7]
    翟冬妍, 吕冠华, 范颖. 旋覆代赭汤现代临床应用概述[J]. 中医药临床杂志, 2024, 36(2): 382-386.
    [8]
    田晶晶, 袁红霞, 张月林, 等. 基于Caspase-3/Bcl-2/Bax信号通路探究加味旋覆代赭汤治疗食管癌前病变的作用机制[J]. 中国中西医结合外科杂志, 2024, 30(2): 258-264. doi: 10.3969/j.issn.1007-6948.2024.02.022
    [9]
    马媛, 荀敬, 王波涛, 等. 旋覆代赭汤对食管癌细胞干性的影响[J]. 中国应用生理学杂志, 2022, 38(1): 62-67.
    [10]
    姚一菲, 孙可欣, 郑荣寿. 《2022全球癌症统计报告》解读: 中国与全球对比[J]. 中国普外基础与临床杂志, 2024, 31(7): 769-780.
    [11]
    TAKEUCHI H, MIYATA H, GOTOH M, et al. A risk model for esophagectomy using data of 5354 patients included in a Japanese nationwide web-based database[J]. Ann Surg, 2014, 260(2): 259-266. doi: 10.1097/SLA.0000000000000644
    [12]
    ELLIOTT J A, DOCHERTY N G, ECKHARDT H G, et al. Weight loss, satiety, and the postprandial gut hormone response after esophagectomy: a prospective study[J]. Ann Surg, 2017, 266(1): 82-90. doi: 10.1097/SLA.0000000000001918
    [13]
    孙千惠, 朱广辉, 许博文, 等. 基于气陷理论探析恶性肿瘤术后中医药治疗与康复思路[J]. 中医杂志, 2024, 65(11): 1120-1125.
    [14]
    李奕, 庞博, 花宝金, 等. 胃肠恶性肿瘤从"通道"立论的中医药治疗策略与思考[J]. 中华中医药杂志, 2023, 38(11): 5344-5347.
    [15]
    田硕, 刘万里, 苏坤涵, 等. 旋覆代赭汤临床应用研究进展[J]. 亚太传统医药, 2021, 17(7): 205-209.
    [16]
    邹利艳. 旋覆代赭汤联合针刺治疗胃癌术后胃瘫综合征31例[J]. 湖南中医杂志, 2020, 36(4): 52-54.
    [17]
    向梅, 赵东丽, 梁宪斌, 等. 旋覆代赭汤联合耳穴按压对黑色素瘤化疗后不良反应的临床观察[J]. 实用中医内科杂志, 2020, 34(5): 109-112.
    [18]
    谭林深, 朴瑛, 郑振东. 旋覆代赭汤加味治疗胰腺癌术后外分泌功能不全临床疗效观察[J]. 临床军医杂志, 2020, 48(1): 44-46.
  • Cited by

    Periodical cited type(6)

    1. 王晓娜,尹健,赵艳春. 右美托咪定联合利多卡因对脑肿瘤切除手术患者的脑保护效应. 贵州医科大学学报. 2023(02): 222-227 .
    2. 何丽丽,周兴,刘媛媛,雷亨发,何军民. 右美托咪定联合纳布啡或舒芬太尼用于老年患者钻孔引流术的临床效果. 江苏医药. 2023(05): 487-490 .
    3. 周美含. 右美托咪定对老年患者全身麻醉术后认知功能障碍的影响. 中华养生保健. 2023(02): 185-187 .
    4. 赵亮,徐阳阳. 右美托咪定对脑膜瘤患者脑源性神经生长因子水平及认知功能的影响. 中国肿瘤临床与康复. 2022(08): 902-905 .
    5. 郭其发,杨成亮,王艺丹,沈通桃. 无阿片药麻醉诱导对气管插管患者血流动力学的影响. 实用临床医药杂志. 2022(22): 56-59 . 本站查看
    6. 申素峰,李景义,胡强夫. 右美托咪定与丙泊酚复合麻醉对脑膜瘤手术患者的麻醉效果及对血流动力学及脑组织的保护作用. 实用癌症杂志. 2022(12): 1971-1974 .

    Other cited types(0)

Catalog

    Article views (54) PDF downloads (7) Cited by(6)

    /

    DownLoad:  Full-Size Img  PowerPoint
    Return
    Return